A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
Study sponsor: PTC Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-12-31Estimated
Enrollment · participants130Actual
Source updated2025-10-30Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.